COVID-19 and “Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation”

Themain focus would be on the novel concept of ‘Multi-Patch Vaccine’ to combat the SARS-CoV-2 and its variants. The content of the talk would be mainly from the following three publications:

Vaccines Targeting Numerous Coronavirus Antigens, Ensuring Broader Global Population Coverage: Multi-epitope and Multi-patch Vaccines; https://pubmed.ncbi.nlm.nih.gov/34914046/

Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwide; https://pubmed.ncbi.nlm.nih.gov/33155524/

Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and Validation; https://pubmed.ncbi.nlm.nih.gov/32776022/